Researchers at St. Jude Children's Research Hospital have developed AdaptiveFlow, an open-source AI platform designed to significantly reduce the computational cost of screening large libraries of drug-like molecules. This advancement aims to make extensive searches more accessible, potentially accelerating the pursuit of treatments for challenging diseases like cancer. AI
IMPACT Accelerates drug discovery by reducing computational costs for screening molecular libraries.
RANK_REASON The cluster describes the release of an open-source AI platform for drug discovery research. [lever_c_demoted from research: ic=1 ai=0.7]
Read on Mastodon — mastodon.social →
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →